Abstract
Protein phosphorylation is a dynamic post-translational modification that plays a critical role in the regulation of a wide spectrum of biological events and cellular functions including signal transduction, gene expression, cell proliferation, and apoptosis. Determination of the sites and magnitudes of protein phosphorylation has been an essential step in the analysis of the control of many biological systems. A high throughput analysis of phosphorylation of proteins would provide a simple, logical, and useful tool for a functional dissection and prediction of biological functions and signaling pathways in association with these important molecular events. We have developed a functional proteomics technique using the ProteinChip array-based SELDI-TOF-MS analysis for high throughput profiling of phosphoproteins/phosphopeptides in human serum for the early detection and diagnosis as well as for the molecular staging of human cancer. The methodology and experimental approach consists of five steps: (1) generation of a total peptide pool of serum proteins by a global trypsin digestion; (2) rapid isolation of phosphopeptides from the total serum peptide pool by an affinity selection, purification, and enrichment using a novel automated micro-bioprocessing system with phospho-antibody-conjugated paramagnetic beads and a hybrid magnet plate; (3) high throughput phosphopeptide analysis on ProteinChip arrays by automated SELDI-TOF-MS; and (4) bioinformatics and statistical methods for data analysis. This method with appropriate modifications may be equally applicable to serine-, threonine- and tyrosine-phosphorylated proteins and for selectively isolating, profiling, and identifying phosphopeptides present in a highly complex phosphor-peptide mixture prepared from various human specimens such as cells, tissue samples, and serum and other body fluids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hunter, T. (2000) Signaling–2000 and beyond. Cell. 100, 113–127.
Oda,Y., Huang, K., Cross, F.R., Cowburn, D., and Chait, B.T. (1999) Accurate quantitation of protein expression and site-specific phosphorylation. Proc. Natl. Acad. Sci. USA. 96, 6591–6596.
Oda,Y., Nagasu,T., and Chait, B.T. (2001) Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19, 379–382.
Peters, E.C., Brock,A., and Ficarro, S.B. (2004) Exploring the phosphoproteome with mass spectrometry. Mini-Rev. Med. Chem. 4, 313–324.
Johnson, S.A. and Hunter, T. (2005) Kinomics: methods for deciphering the kinome. Nat. Methods. 2, 17–25.
York, J.D. and Hunter, T. (2004) Signal transduction. Unexpected mediators of protein phosphorylation. Science. 306, 2053–2055.
Johnson, S.A. and Hunter, T. (2004) Phosphoproteomics finds its timing. Nat. Biotechnol. 22, 1093–1094.
Manning, G., Whyte, D.B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science. 298, 1912–1934.
Rush, J., Moritz, A., Lee, K.A., Guo, A., Goss,V.L., Spek, E.J. et al. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94–101.
Hunter, T. (2002) Tyrosine phosphorylation in cell signaling and disease. Keio J. Med. 51, 61–71.
Hunter, T. (1998) The role of tyrosine phosphorylation in cell growth and disease. Harvey Lectures. 94, 81–119.
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A. et al. (2004) Protein tyrosine phosphatases in the human genome. Cell. 117, 699–711.
Hornbeck, P.V., Chabra, I., Kornhauser, J.M., Skrzypek, E., and Zhang, B. (2004) PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics. 4, 1551–1561.
Gerber, S.A., Rush, J., Stemman, O., Kirschner, M.W., and Gygi, S.P. (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA. 100, 6940–6945.
Steen, H., Jebanathirajah, J.A., Rush, J., Morrice, N., and Kirschner, M.W. (2006) Phosphorylation analysis by mass spectrometry: myths, facts, and the consequences for qualitative and quantitative measurements. Mol. Cell. Proteomics. 5, 172–181.
Pan, S., Zhang, H., Rush, J., Eng, J., Zhang, N., Patterson, D. et al. (2005) High throughput proteome screening for biomarker detection. Mol. Cell. Proteomics. 4, 182–190.
Brill, L.M., Salomon, A.R., Ficarro, S.B., Mukherji, M., Stettler-Gill, M., and Peters, E.C. (2004) Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal. Chem. 76, 2763–2772.
Mann, M., Ong, S.E., Gronborg, M., Steen, H., Jensen, O.N., and Pandey, A. (2002) Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 20, 261–268.
Salomon, A.R., Ficarro, S.B., Brill, L.M., Brinker, A., Phung, Q.T., Ericson, C. et al. (2003) Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc. Natl. Acad. Sci. USA. 100, 443–448.
Zhou, H., Watts, J.D., and Aebersold, R. (2001) A systematic approach to the analysis of protein phosphorylation. Nat. Biotechnol. 19, 375–378.
Zhang, H., Zha, X., Tan, Y., Hornbeck, P.V., Mastrangelo, A.J., Alessi, D.R. et al. (2002) Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem. 277, 39379–39387.
Rush, J., Moritz, A., Lee,K. A., Guo, A., Goss, V.L., Spek, E.J. et al. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94–101.
Mann, M. (1999) Quantitative proteomics? Nat. Biotechnol. 17, 954–955.
Rice, R.H., Means, G.E., and Brown, W.D. (1977) Stabilization of Bovine Trypsin by Reductive Methylation. Biochim. Biophys. Acta. 492, 316–321.
Elkin, H., Kapur, T., Humphries, D., Pollard, M., Nammon, N., and Hawkins, T. (2002) Magnetic bead purification of labeled DNA fragments for high throughput capillary electorphoresis sequencing. Biotechniques. 32, 1296–1307.
Humphries, D.E., Pollard, M.J., and Elkin, C.J. High Performance Hybrid Magnetic Structure for Biotechnology Applications. The Regents of the University of California. 10/305658 (6954128B2). 2002 California, USA (Patent).
Aebersold, R., Rist, B., and Gygi, S.P. (2000) Quantitative proteome analysis: methods and applications. Annal. New York Acad. Sci. 919, 33–47.
Aebersold, R. and Mann, M. (2003) Mass spectrometry-based proteomics. Nature. 422, 198–207.
Anderson, N.L., Matheson, A.D., and Steiner, S. (2000) Proteomics: applications in basic and applied biology. Curr. Opin. Biotechnol. 11, 408–412.
Anderson, N.L. and Anderson, N.G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 1, 845–867.
Celis, J.E.G. (2003) Proteomics in translational cancer research: Toward an integrated approach. Cancer Cell. 3, 9–15.
Coombes, K.R., Morris, J.S., Hu, J., Edmonson, S.R., and Baggerly, K.A. (2005) Serum proteomics profiling–a young technology begins to mature. Nat. Biotechnol. 23, 291–292.
Petricoin, E.F., Zoon, K.C., Kohn, E.C., Barrett, J.C., and Liotta, L.A. (2002) Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 1, 683–695.
Petricoin, E.F. and Liotta, L.A. (2004) SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 15, 24–30.
Sauer, S., Lange, B.M., Gobom, J., Nyarsik, L., Seitz, H., and Lehrach, H. (2005) Miniaturization in functional genomics and proteomics. Nat. Rev. Genet. 6, 465–476.
Shrivastava, A., von Wronski, M.A., Sato, A.K., et al. (2005) A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases. Prot. Engin., Design. Select. 18, 417–424.
Sato, A.K., Sexton, D.J., Morganelli, L.A., et al. (2002) Development of mammalian serum albumin affinity purification media by peptide phage display. Biotechnol. Prog. 18, 182–192.
Adkins, J.N., Varnum, S.M., Auberry, K.J., et al. (2002) Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics. 1, 947–955.
Chan, K.C., Lucas, D.A., Hise, D., GM et al. (2004) Analysis of the human serum proteome. Clin. Proteomics J. 1, 101–225.
Ressom, H.W., Varghese, R.S., Abdel-Hamid, M., et al. (2005) Analysis of mass spectral serum profiles for biomarker selection. Bioinformatics. 21, 4039–4045.
Veenstra, T.D., Prieto, D.A., and Conrads, T.P. (2004) Proteomic patterns for early cancer detection. Drug Discov. Today. 9, 889–897.
Yu, L.R., Zhou, M., Conrads, T.P., and Veenstra, T.D. (2003) Diagnostic proteomics: serum proteomic patterns for the detection of early stage cancers. Dis. Markers. 19, 209–218.
Issaq, H.J., Conrads, T.P., Prieto, D.A., Tirumalai, R., and Veenstra, T.D. (2003) SELDI-TOF MS for diagnostic proteomics. Anal. Chem. 75, 148A–155A.
Issaq, H.J., Veenstra, T.D., Conrads, T.P., and Felschow, D. (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292, 587–592.
Rosenblatt, K.P., Bryant-Greenwood, P., Killian, J.K., et al. (2004) Serum proteomics in cancer diagnosis and management. Ann. Rev. Med. 55, 97–112.
Diamandis, E.P. (2004) Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J. Natl. Cancer Inst. 96, 353–356.
Koomen, J.M., Li, D., Xiao, L.C., et al. (2005) Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J. Prot. Res. 4, 972–981.
Semmes, O.J., Feng, Z., Adam, B.L., et al. (2005) Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin. Chem. 51, 102–112.
Baggerly, K.A., Morris, J.S., Wang, J., Gold, D., Xiao, L.C., and Coombes, K.R. (2003) A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples. Proteomics. 3, 1667–1672.
Baggerly, K.A., Morris, J.S., and Coombes, K.R. (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics. 20, 777–785.
Baggerly, K.A., Morris, J.S., Edmonson, S.R., and Coombes, K.R. (2005) Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 97, 307–309.
Coombes, K.R., Tsavachidis, S., Morris, J.S., Baggerly, K.A., Hung, M.C., and Kuerer, H.M. (2005) Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform. Proteomics. 5, 4107–4117.
Coombes, K.R. (2005) Analysis of mass spectrometry profiles of the serum proteome. Clin. Chem. 51, 1–2.
Coombes, K.R., Fritsche, H.A., Jr., Clarke, C., et al. (2003) Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin. Chem. 49, 1615–1623.
Baggerly, K.A., Edmonson, S.R., Morris, J.S., and Coombes, K.R. (2004) High-resolution serum proteomic patterns for ovarian cancer detection. Endocr. Relat. Cancer. 11, 583–584.
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., and Golani, I. (2001) Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279–284.
Morris, J.S., Coombes, K.R., Koomen, J., Baggerly, K.A., and Kobayashi, R. (2005) Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum. Bioinformatics. 21, 1764–1775.
Pounds, S. and Cheng, C. (2004) Improving false discovery rate estimation. Bioinformatics. 20, 1737–1745.
Pounds, S. and Cheng, C. (2005) Sample size determination for the false discovery rate. Bioinformatics. 21, 4263–4271.
Acknowledgments
The authors would like to thank Drs. Xifeng Wu and Margaret Spitz for providing lung cancer serum samples for serum phosphopeptide profiling and analysis and Dr. Kevin Coombes for bioinformatics and statistical analysis, at The University of Texas M. D. Anderson Cancer Center, Houston, TX, and David Humphries at Lawrence Berkeley National Laboratory, Oak Land, CA for developing hybrid magnetic plates for serum phosphopeptide enrichment. This work was partially supported by grants from NIH/NCI SPORE P50CA070907, RO1CA116322, and MMHCC U01CA105352; DOD PROSPECT W81XWH-0710306; The University of Texas M. D. Anderson Cancer Center Support Core Grant (CA16672).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ji, L., Jayachandran, G., Roth, J.A. (2012). High Throughput Profiling of Serum Phosphoproteins/Peptides Using the SELDI-TOF-MS Platform. In: Clarke, C., McCarthy, D. (eds) SELDI-TOF Mass Spectrometry. Methods in Molecular Biology, vol 818. Springer, New York, NY. https://doi.org/10.1007/978-1-61779-418-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-61779-418-6_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-61779-417-9
Online ISBN: 978-1-61779-418-6
eBook Packages: Springer Protocols